• Medicine Name - Taffic
  • API - Bictegravir, Emtricitabine and Tenofovir Alafenamide
  • Packaging - Tablets
  • Strength - 50 mg/200 mg /25 mg

What is Taffic and what it is used for?

Taffic is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is used as a complete regimen to treat HIV-1 infection in adult patients who have previously not taken antiretroviral treatment or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA below 50 copies per mL) on a stable antiretroviral regimen for minimum 90 days with no history of treatment failure and unspecified substitutions linked with resistance to the individual components of Taffic.


Taffic tablet is a three-drug fixed dose combination (FDC) medicinal product containing 50 mg of bictegravir (BIC), 200 mg of emtricitabine (FTC), and 25 mg of tenofovir alafenamide (TAF). The recommended dosage is one tablet taken by mouth (orally) once daily with or without food. Patients should take dosage of Taffic on a regular dosing schedule and avoid missing doses as it can result in the development of resistance.

Side effects

The most commonly reported side effects due to Taffic include: nausea, diarrhea, and headache.

Warnings And Precautions
  • Before or when initiating bictegravir emtricitabine and tenofovir alafenamide, test patients for hepatitis B virus infection.
  • Before or when initiating Taffic, and during treatment with Taffic, assess serum creatinine, estimated creatinine clearance, urine glucose and urine protein. Patients with chronic kidney disease need to be assessed for serum phosphorus.
  • The bictegravir emtricitabine tenofovir treatment is not recommended in patients with estimated creatinine clearance below 30 mL per minute.
  • Taffic therapy is not recommended in patients with severe hepatic impairment (Child-Pugh Class C).
  • Patients with HIV-1 need to be tested for the existence of chronic hepatitis B virus (HBV) infection prior to or when initiating antiretroviral therapy.
  • Patients coinfected with both HIV-1 and HBV who discontinue taffic tablets need to be precisely assessed with clinical as well as laboratory follow-up for a minimum several months after stopping treatment.
  • Patients taking tenofovir prodrugs with impaired renal function and those taking nephrotoxic agents including non-steroidal anti-inflammatory medicines are at higher risk of developing renal-related adverse reactions.
  • Treatment with bictegravir emtricitabine tenofovir alafenamide should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity.
  • Patients should be informed that there is an antiretroviral pregnancy registry to monitor fetal outcomes of pregnant women exposed to Taffic.
  • Women with HIV-1 infection should not breastfeed because HIV-1 can be passed to the baby in breast milk.
Storage and Handling

Store the Taffic Tablets below 30 °C (86 °F). Keep the container tightly closed. Dispense only in the original container.

Commonly asked questions:

Taffic, a once-a-day single pill, is a combination of three medications; Bictegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg).

Taffic is supplied as Tablets: 50 mg of bictegravir (equivalent to 52.5 mg of bictegravir sodium), 200 mg of emtricitabine, and 25 mg of tenofovir alafenamide (equivalent to 28 mg of tenofovir alafenamide fumarate). 

Taffic typically comes as tablets to be administered orally (by mouth). 

Taffic specifically is a type of antiretroviral combination medication.

Taffic is a 3-in-1 combination drug that helps to prevent HIV from multiplying and works together to reduce the level of HIV in the patient’s blood to undetectable levels. This reduces the prospects of patients developing various HIV associated illnesses, thereby enhancing their QoL (Quality of Life). 

You can buy Taffic from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

Patients can simply fill the order form or can send mail at info@ikrispharmanetwork.com. Patients can also send WhatsApp messages to +91 8130290915 or can dial Toll-Free number: 18008891064. We will reply ASAP with the details of the Taffic price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.


All Trademarks and Brands that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Taffic is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Cooperate Sourcing, reseller and Pharmacies.